Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,580 JPY | +0.83% | -0.13% | +1.22% |
2023 | Delta-Fly Pharma, Inc. announced that it has received ¥503.7238 million in funding from Nippon Chemiphar Co., Ltd. | CI |
2023 | Global EV battery supply chain puzzles over China graphite curbs | RE |
ETFs positioned on Nippon Chemiphar Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 14 M€ | +9.43% | ||
0.00% | 17 M€ | +18.02% | - | |
0.00% | 138,841 M€ | +17.32% | ||
0.00% | 19,753 M€ | +16.26% | - |
1st Jan change | Capi. | |
---|---|---|
+1.22% | 36.04M | |
+50.70% | 795B | |
+41.96% | 627B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 294B | |
+18.02% | 245B | |
+1.27% | 222B | |
+11.95% | 215B | |
+3.68% | 160B |
- Stock Market
- Equities
- 4539 Stock
- Funds and ETFs Nippon Chemiphar Co., Ltd.